Screener
Apogee Therapeutics, Inc. APGE Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Apogee Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 7:20 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-215698
| Line item | MARCH 31,2026 | DECEMBER 31,2025 |
|---|---|---|
| Accounts payable | $1,237 | $1,221 |
| Lease liability | 3,138 | 3,504 |
| Accrued expenses and other current liabilities | 28,577 | 23,181 |
| Total current liabilities | 32,952 | 27,906 |
| Long-term liabilities: | ||
| Lease liability, net of current | 4,909 | 5,345 |
| Total liabilities | 37,861 | 33,251 |
| Commitments and contingencies (Note 9) |
Item 6. [Exhibits](#item_6_exhibits) [71](#item_6_exhibits)
FAQ
- What is Apogee Therapeutics, Inc.'s total current liabilities?
- Apogee Therapeutics, Inc. (APGE) reported total current liabilities of $32.95M in Q1 2026.
- How has Apogee Therapeutics, Inc.'s total current liabilities changed year-over-year?
- Apogee Therapeutics, Inc.'s total current liabilities decreased by 0.0% year-over-year, from $32.96M to $32.95M.
- What is the long-term trend for Apogee Therapeutics, Inc.'s total current liabilities?
- Over 3 years (2022 to 2025), Apogee Therapeutics, Inc.'s total current liabilities has grown at a 40.9% compound annual growth rate (CAGR), from $9.98M to $27.91M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Apogee Therapeutics, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude